CD8A and neoplasm: The first is a clinical study that recruited five patients who underwent subtotal removal of malignant glioma without receiving other therapy.161 All patients exhibited a specific CD8+ cytotoxic T-cell response after treatment with autologous tumor mRNA-loaded DCs, and among them, three showed potent cytolytic activity against autologous glioma cells.